FPH Fisher & Paykel expects to add $10M to its profit expectations for FY25 Fisher & Paykel Healthcare Corporation Ltd has reported updated guidance for its underlying profit and revenue for the 2025 fiscal year. Caroline Smith 1 day ago ASX News Healthcare Medical Devices
CU6 US FDA awards Clarity Pharma's novel prostate cancer PET scan imaging compound fast track status Clarity Pharmaceuticals (ASX:CU6) has revealed it's received fast track status from the US FDA for its prostate cancer imaging compound designed for PET scans. Jonathon Davidson 2 days ago ASX News Healthcare
OSX Osteopore winds up 3D printed bone implant study bankrolled by the Chilean Government Osteopore Limited (ASX:OSX) has reported its conclusion of a research program funded by the Chilean government to create a 3D printed bone implant to aid regenerative healing. Jonathon Davidson 2 days ago ASX News Healthcare Medical Instruments & Supplies
Reporting wrap: Capitol Health, Genesis Energy, SkyCity Entertainment, Medibank Capitol Health Ltd, Genesis Energy Ltd, SkyCity Entertainment Group Ltd and Medibank Private Ltd were all reporting final year results. Caroline Smith 2 days ago ASX News Consumer Cyclical Energy Financial Services Healthcare
HIQ Mouthguard concussion sensor tech developer HIT IQ wins second US patent HITIQ Ltd (ASX:HIQ) has received approval for its second US patent covering its proprietary mouthguard tech, one that contains sensors designed to map blows to the head in the name of concussion research and prevention. Jonathon Davidson 3 days ago ASX News Healthcare Technology Medical Devices
IIQ INOVIQ says it has found a way to test blood for Parkinson's Disease – after Alzheimer's success in June If you're looking for a reason why INOVIQ (ASX:IIQ) shares jumped 6% out the gate on Tuesday, it's this – after announcing similar success for Alzheimer's patients in June, the company now says it can test blood for Parkinson's. Jonathon Davidson 4 days ago ASX News Healthcare
NOX Noxopharm aims for autoimmune market with first human trial of SOF-SKN Noxopharm Ltd is planning the first human trial to assess novel drug SOF-SKN, which aims to treat autoimmune conditions. Caroline Smith 5 days ago ASX News Healthcare Biotechnology
OSL Oncosil device successfully treats pancreatic cancer in Türkiye Oncosil Medical Ltd reported the successful reduction in tumor size through the use of its flagship device and chemotherapy. Caroline Smith 15 Aug 2024 12:27 (AEST) ASX News Healthcare Technology Scientific & Technical Instruments
RGT Is the ASX OK? Argent Biopharma plummets as it leaves the bourse one day after Marley spoon; low liquidity blamed Argent Biopharma (ASX:RGT) has announced it's leaving the ASX because it can't attract investment in Australia – one day after Marley Spoon announced it will leave the bourse for the same reason. Jonathon Davidson 15 Aug 2024 11:17 (AEST) ASX News Healthcare
GTG Genetic Tech boosts reach of the geneType risk tests in 42 countries with global launch Genetic Technologies Ltd has announced the global launch of its geneType risk tests on the EasyDNA platform. Caroline Smith 15 Aug 2024 10:27 (AEST) ASX News Healthcare Technology Scientific & Technical Instruments
NOX Noxopharm jumps 35% on news its drug CRO-67 reduced human pancreatic tumour cells in mice Shares in Noxopharm (ASX:NOX) jumped nearly 40% in morning trades on Wednesday as the company announced its experimental drug CRO-67 reduced human pancreatic tumour cells implanted into mice. Jonathon Davidson 14 Aug 2024 11:16 (AEST) ASX News Healthcare Biotechnology
IMM Immutep doses first human patient with IMP761 – a possible broad-ranging autoimmune treatment Immutep (ASX:IMM) has confirmed it's dosed the first human patient with its LAG-3 based autoimmune drug candidate IMP761. Jonathon Davidson 14 Aug 2024 09:22 (AEST) ASX News Healthcare Biotechnology
ACW Actinogen Medical weighs in on its latest results to market Actinogen Medical (ASX:ACW) recently announced results from its XanaCIDD Phase 2a trials, which demonstrated the drug's significant clinical and statistical benefits over a placebo in treating depression. Jonathon Davidson 13 Aug 2024 10:33 (AEST) ASX News Healthcare Biotechnology